(Q38044067)

27 August 2017

title

Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation (English)

1 reference

27 August 2017

1 reference

1 reference

Maura Corsetti

2

0 references

author name string

Jan Tack

series ordinal

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 October 2012

1 reference

Expert Opinion on Drug Metabolism & Toxicology

27 August 2017

published in

1 reference

27 August 2017

volume

8

1 reference

27 August 2017

issue

10

1 reference

27 August 2017

page(s)

1327-1335

1 reference

Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Quality of life in children and adults with constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Treatment of chronic constipation: current pharmacologic approaches and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Current and future therapies for chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Diagnosis and treatment of chronic constipation--a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Cisapride for the treatment of chronic idiopathic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

5-HT4 receptor agonists: similar but not the same

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Peristalsis evoked by 5-HT and renzapride: evidence for putative 5-HT4 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Presynaptic modulation of cholinergic and non-cholinergic fast synaptic transmission in the myenteric plexus of guinea pig ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

An improved in vitro bioassay for the study of 5-HT(4) receptors in the human isolated large intestinal circular muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

5-HT4 receptors located on cholinergic nerves in human colon circular muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

5-HT(4) receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

5-HT(4) receptors mediating enhancement of contractility in canine stomach; an in vitro and in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Presynaptic modulation of cholinergic neurotransmission in the human proximal stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Effect of enterokinetic prucalopride on intestinal motility in fast rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Effects of the enterokinetic prucalopride (R093877) on colonic motility in fasted dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Selective desensitization of the 5-HT4 receptor-mediated response in pig atrium but not in stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Electrophysiological effects of prucalopride, a novel enterokinetic agent, on isolated atrial myocytes from patients treated with beta-adrenoceptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

A placebo-controlled trial of prucalopride for severe chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Psychometric validation of a constipation symptom assessment questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Functional bowel disorders and functional abdominal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Treatment of GI dysmotility in scleroderma with the new enterokinetic agent prucalopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Prucalopride for chronic intestinal pseudo-obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.719497

10.1517/17425255.2012.719497

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference